RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tron Pharmaceuticals Stock

Tron Pharmaceuticals P/S 2024

Tron Pharmaceuticals P/S

99.31

Ticker

TGRP

ISIN

US8970121005

WKN

A2QL98

As of Sep 28, 2024, Tron Pharmaceuticals's P/S ratio stood at 99.31, a 0% change from the 0 P/S ratio recorded in the previous year.

The Tron Pharmaceuticals P/S history

Tron Pharmaceuticals Aktienanalyse

What does Tron Pharmaceuticals do?

The Tron Group Inc is a leading company specializing in the development and production of innovative products in various industries. It was founded in 1992 and is headquartered in New York City, with many branches worldwide. The beginnings of Tron Group Inc are in the LED lighting industry. As a pioneer in this field, the company has developed groundbreaking products that are now used globally in entertainment, retail, public events, and many other areas. With its unique ability to recognize and implement the latest technologies on the market, the company has quickly established itself as a leading provider in the lighting industry. In addition to the lighting business, the company has expanded its activities into many other industries. Today, Tron Group Inc is a significant player in the pharmaceutical industry, biomedical research, water and wastewater treatment, waste management, medical device production, and many other fields. The business model of Tron Group Inc is based on close collaboration with customers and partners in various industries. The company works closely with other companies to develop innovative products and solutions that meet the needs of its customers and society. The company is always searching for new technologies and optimization opportunities, integrating them into its products and services to achieve maximum customer satisfaction. Tron Group Inc is divided into various divisions, each offering specific products and services. An important division is Tron LED, which still focuses on manufacturing LED lighting solutions. With its wide range of products and services, Tron LED is able to meet all of its customers' requirements, from simple garden waterfall lighting to complex data visualization at concerts and major events. Another important division of Tron Group Inc is Tron Biomedical. This division offers a variety of products and services for biomedical research, including cell counting and analysis devices, artificial insemination devices, and food analysis systems. Tron Biomedical strives to integrate the latest and most advanced technologies into its products and services to advance research in this field and achieve groundbreaking advances in medicine. In addition to these main divisions, Tron Group Inc also offers a wide range of products and services in other industries. Tron Waste and Water provide innovative solutions for water and wastewater treatment and waste management, while Tron Medical Equipment manufactures medical devices and equipment such as ultrasound systems, injection systems, and patient monitoring units. Overall, Tron Group Inc is an innovative company with a wide range of products and services, constantly searching for new technologies and solutions to best serve its customers and society. With its many years of experience and commitment to high-quality products, Tron Group Inc has established itself as a leading provider in many industries and remains a key player in the global market. Tron Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Tron Pharmaceuticals's P/S Ratio

Tron Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Tron Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Tron Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Tron Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Tron Pharmaceuticals stock

What is the price-to-earnings ratio of Tron Pharmaceuticals?

The price-earnings ratio of Tron Pharmaceuticals is currently 99.31.

How has the price-earnings ratio of Tron Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Tron Pharmaceuticals has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Tron Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Tron Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Tron Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Tron Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Tron Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Tron Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Tron Pharmaceuticals?

Some factors that influence the price-earnings ratio of Tron Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Tron Pharmaceuticals pay?

Over the past 12 months, Tron Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tron Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Tron Pharmaceuticals?

The current dividend yield of Tron Pharmaceuticals is .

When does Tron Pharmaceuticals pay dividends?

Tron Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tron Pharmaceuticals?

Tron Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Tron Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tron Pharmaceuticals located?

Tron Pharmaceuticals is assigned to the '-' sector.

Wann musste ich die Aktien von Tron Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tron Pharmaceuticals from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Tron Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Tron Pharmaceuticals in the year 2023?

In the year 2023, Tron Pharmaceuticals distributed 0 USD as dividends.

In which currency does Tron Pharmaceuticals pay out the dividend?

The dividends of Tron Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tron Pharmaceuticals

Our stock analysis for Tron Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tron Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.